Business Description
Citius Pharmaceuticals is a New Jersey-based company founded in 2007 that develops and sells medical treatments for serious conditions. Its flagship product, LYMPHIR, has received FDA approval as a targeted therapy for a type of skin cancer called cutaneous T-cell lymphoma. The company also has several treatments in late-stage development, including solutions for catheter-related bloodstream infections, hemorrhoid relief, and a stem cell therapy for acute respiratory distress syndrome.
